查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1810929

2025年全球靜脈治療解決方案市場報告

Intravenous Therapy Solutions Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年靜脈治療解決方案市場將快速成長，到2029年將達到193.3億美元，複合年成長率為10.1%。預測期內，老年人口的成長、家庭醫療保健服務的擴展、快速補液療法需求的上升、胃腸道疾病患病率的上升以及一次性靜脈輸液組件使用量的增加預計將推動這一成長。主要趨勢包括靜脈給藥系統的進步、向家庭靜脈治療的轉變、智慧型輸液幫浦的整合、生物製藥和特殊藥物輸注量的增加，以及對個人化靜脈營養療法日益成長的偏好。

微創手術日益成長的需求預計將推動靜脈治療解決方案市場的成長。微創手術涉及微創切口和對身體的侵入，通常可加快恢復速度並減少併發症。這種日益成長的偏好是由於治療方法能夠減輕術後疼痛、加快恢復速度並增加患者在康復期間的舒適度。靜脈治療解決方案透過將液體、藥物和營養物質直接輸送到血液中來促進這些治療，促進有效的患者護理並加速康復。例如，2024 年 6 月，美國整形外科醫師協會報告稱，2023 年微創手術將成長 7%，超過外科手術 2% 的成長率。因此，微創手術日益成長的需求正在推動靜脈治療解決方案市場的擴張。

靜脈治療解決方案市場的主要企業正專注於創新產品，例如即用型藥物輸液溶液，以提高治療效率並減少臨床環境中的準備時間。即用型輸液溶液是預先混合、預先貼標籤的靜脈注射藥物，以標準劑量包裝，無需現場稀釋和配製。 2024 年 5 月，美國製造商 B. Braun Medical Inc. 推出了左乙拉西坦氯化鈉注射液，這是一種用於治療癲癇的即用型抗驚厥靜脈溶液。本產品具有標準化的濃度和體積，無需在照護現場稀釋和配製。該製劑預先混合在靈活的容器中，確保劑量準確性，降低污染風險，並提高急診和住院環境中醫療保健提供者的便利性。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球靜脈治療解決方案：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球靜脈治療解決方案市場：成長率分析
  • 全球靜脈注射治療解決方案市場表現：規模與成長，2019-2024
  • 全球靜脈注射治療解決方案市場預測：規模與成長，2024-2029 年，2034 年
  • 全球靜脈治療解決方案：總目標市場（TAM）

第6章 市場細分

  • 全球靜脈注射治療解決方案市場：依產品類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 晶體
  • 膠體
  • 血液製品
  • 其他產品類型
  • 全球靜脈注射治療解決方案市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 體液和電解質失衡
  • 營養支持
  • 藥物管理
  • 輸血
  • 其他用途
  • 全球靜脈注射治療解決方案市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 門診手術中心
  • 居家照護環境
  • 其他最終用戶
  • 全球靜脈注射治療解決方案市場：按晶體類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 生理食鹽水（0.9%氯化鈉）
  • 半生理食鹽水食鹽水（0.45%氯化鈉）
  • 乳酸林格氏液
  • 葡萄糖溶液
  • 高滲透壓鹽水
  • 全球靜脈注射治療解決方案市場：按膠體（按類型）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 白蛋白
  • 聚葡萄糖
  • 羥乙基澱粉（HES）
  • 明膠
  • 全球靜脈注射治療解決方案市場：依血液製品（按類型）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 紅血球濃縮液（PRBC）
  • 血小板
  • 新鮮冷凍血漿（FFP）
  • 冷沉澱
  • 全球靜脈注射治療解決方案市場：依產品類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 靜脈注射免疫球蛋白（IVIG）
  • 腸外營養解決方案
  • 特殊靜脈注射藥物和添加劑

第7章 區域和國家分析

  • 全球靜脈注射治療解決方案市場：區域表現與預測，2019-2024 年、2024-2029 年、2034 年
  • 全球靜脈注射治療解決方案市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 靜脈治療解決方案市場：競爭格局
  • 靜脈治療解決方案市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Grifols SA
  • Terumo Corporation
  • Dr. Reddy's Laboratories Limited
  • Sichuan Kelun Pharmaceutical Co. Ltd.
  • Teleflex Incorporated
  • Hikma Pharmaceuticals PLC
  • ICU Medical Inc.
  • Biocon Limited
  • B. Braun Melsungen Aktiengesellschaft
  • JW Life Science Corporation
  • AdvaCare Pharma USA
  • Soxa Formulations & Research Pvt. Ltd.
  • Vifor Pharma Management Ltd.
  • Aetos Pharma Private Limited
  • LXIR Medilabs Private Limited

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年靜脈治療解決方案市場：提供新機會的國家
  • 2029年靜脈治療解決方案市場：細分市場帶來新機會
  • 靜脈治療解決方案市場 2029 年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r37031

Intravenous therapy solutions are sterile liquid formulations administered directly into the bloodstream to deliver fluids, medications, nutrients, or electrolytes. These solutions are used to treat conditions such as dehydration, electrolyte imbalances, infections, and to provide essential nutrients when oral intake is not feasible. Typically composed of water, salts, sugars, or medicinal ingredients, they are customized based on individual patient requirements and specific medical conditions.

The primary types of intravenous therapy solutions include crystalloids, colloids, blood products, and others. Crystalloids consist of water mixed with electrolytes and are commonly used for rapid rehydration and fluid balance restoration in urgent medical situations. These solutions serve multiple purposes, including correcting fluid and electrolyte imbalances, supporting nutrition, administering medications, and enabling blood transfusions. They are utilized across a range of healthcare settings, including hospitals, clinics, ambulatory surgical centers, home care environments, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The intravenous therapy solutions market research report is one of a series of new reports from The Business Research Company that provides intravenous therapy solutions market statistics, including the intravenous therapy solutions industry global market size, regional shares, competitors with the intravenous therapy solutions market share, detailed intravenous therapy solutions market segments, market trends, and opportunities, and any further data you may need to thrive in the intravenous therapy solutions industry. These intravenous therapy solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The intravenous therapy solutions market size has grown rapidly in recent years. It will grow from $11.95 billion in 2024 to $13.17 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. Growth during the historic period was driven by rising hospital admissions, an increase in surgical procedures, a growing incidence of dehydration, higher rates of chronic diseases, and enhanced access to healthcare infrastructure.

The intravenous therapy solutions market size is expected to see rapid growth in the next few years. It will grow to $19.33 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. Growth in the forecast period is expected to be driven by the expanding elderly population, growth in home healthcare services, increased demand for rapid rehydration therapies, a rising prevalence of gastrointestinal disorders, and greater use of single-use IV components. Key trends include advancements in intravenous drug delivery systems, a move toward home-based IV therapy, the integration of smart infusion pumps, growth in biologic and specialty drug infusions, and a growing preference for personalized IV nutrition treatments.

The increasing demand for minimally invasive therapies is expected to drive growth in the intravenous therapy solutions market. Minimally invasive therapies involve medical treatments with minimal incisions or bodily entry, often resulting in quicker recovery and fewer complications. This rising preference is attributed to the therapies' ability to reduce postoperative pain, leading to faster recovery and greater patient comfort during healing. Intravenous therapy solutions facilitate these treatments by delivering fluids, medications, and nutrients directly into the bloodstream, promoting effective patient care and accelerated recovery. For example, in June 2024, the American Society of Plastic Surgeons reported that minimally invasive procedures increased by 7% in 2023, surpassing the growth rate of surgical procedures by 2%. Hence, the rising demand for minimally invasive therapies is fueling the expansion of the intravenous therapy solutions market.

Key players in the intravenous therapy solutions market are focusing on innovative products such as ready-to-use drug infusions to improve treatment efficiency and reduce preparation time in clinical environments. Ready-to-use drug infusions consist of pre-mixed and pre-labeled intravenous medications packaged in standardized doses, eliminating the need for on-site dilution or compounding. In May 2024, B. Braun Medical Inc., a US-based manufacturer, introduced Levetiracetam in Sodium Chloride Injection, a ready-to-use intravenous anticonvulsant solution designed for seizure treatment. This product comes in standardized concentrations and volumes, removing the requirement for dilution or compounding at the point of care. The formulation is pre-mixed in a flexible container to ensure dosing accuracy, reduce contamination risks, and improve convenience for healthcare providers in emergency and inpatient settings.

In April 2025, Organon & Co., a US-based healthcare company, acquired the regulatory and commercial rights to Tofidence from Biogen Inc. This acquisition aims to strengthen and expand Organon & Co.'s biosimilars immunology portfolio in the US by including Tofidence to support treatments for multiple arthritis conditions and COVID-19. The company plans to leverage its commercial expertise and market access capabilities to foster long-term growth in the immunology sector. Biogen Inc. is a US-based biotechnology firm specializing in intravenous therapy solutions like Tofidence.

Major players in the intravenous therapy solutions market are Pfizer Inc., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Dr. Reddy's Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Teleflex Incorporated, Hikma Pharmaceuticals PLC, ICU Medical Inc., Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited.

North America was the largest region in the intravenous therapy solutions market in 2024. The regions covered in intravenous therapy solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the intravenous therapy solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intravenous therapy solutions market consists of sales of saline solutions, dextrose solutions, lactated Ringer's solutions, amino acid solutions, vitamin and mineral infusions, IV antibiotic solutions, chemotherapy IV solutions, and parenteral nutrition solutions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intravenous Therapy Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intravenous therapy solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intravenous therapy solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intravenous therapy solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Crystalloids; Colloids; Blood Products; Other Product Types
  • 2) By Application: Fluid And Electrolyte Imbalance; Nutritional Support; Medication Administration; Blood Transfusion; Other Applications
  • 3) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Home Care Settings; Other End-Users
  • Subsegments:
  • 1) By Crystalloids: Normal Saline (0.9% Sodium Chloride); Half Normal Saline (0.45% Sodium Chloride); Lactated Ringer's Solution; Dextrose Solutions; Hypertonic Saline
  • 2) By Colloids: Albumin; Dextran; Hydroxyethyl Starch (HES); Gelatin
  • 3) By Blood Products: Packed Red Blood Cells (PRBCs); Platelets; Fresh Frozen Plasma (FFP); Cryoprecipitate
  • 4) By Other Product: Intravenous Immunoglobulins (IVIG); Parenteral Nutrition Solutions; Specialty Intravenous Drugs And Additives
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Otsuka Pharmaceutical Co. Ltd.; Baxter International Inc.; Fresenius Kabi AG; Grifols S.A.; Terumo Corporation; Dr. Reddy's Laboratories Limited; Sichuan Kelun Pharmaceutical Co. Ltd.; Teleflex Incorporated; Hikma Pharmaceuticals PLC; ICU Medical Inc.; Biocon Limited; B. Braun Melsungen Aktiengesellschaft; JW Life Science Corporation; AdvaCare Pharma USA; Soxa Formulations & Research Pvt. Ltd.; Vifor Pharma Management Ltd.; Aetos Pharma Private Limited; LXIR Medilabs Private Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intravenous Therapy Solutions Market Characteristics

3. Intravenous Therapy Solutions Market Trends And Strategies

4. Intravenous Therapy Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Intravenous Therapy Solutions Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Intravenous Therapy Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Intravenous Therapy Solutions Market Growth Rate Analysis
  • 5.4. Global Intravenous Therapy Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Intravenous Therapy Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Intravenous Therapy Solutions Total Addressable Market (TAM)

6. Intravenous Therapy Solutions Market Segmentation

  • 6.1. Global Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Crystalloids
  • Colloids
  • Blood Products
  • Other Product Types
  • 6.2. Global Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fluid And Electrolyte Imbalance
  • Nutritional Support
  • Medication Administration
  • Blood Transfusion
  • Other Applications
  • 6.3. Global Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Other End-Users
  • 6.4. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Crystalloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Normal Saline (0.9% Sodium Chloride)
  • Half Normal Saline (0.45% Sodium Chloride)
  • Lactated Ringer's Solution
  • Dextrose Solutions
  • Hypertonic Saline
  • 6.5. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Colloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Albumin
  • Dextran
  • Hydroxyethyl Starch (HES)
  • Gelatin
  • 6.6. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Blood Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Packed Red Blood Cells (PRBCs)
  • Platelets
  • Fresh Frozen Plasma (FFP)
  • Cryoprecipitate
  • 6.7. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intravenous Immunoglobulins (IVIG)
  • Parenteral Nutrition Solutions
  • Specialty Intravenous Drugs And Additives

7. Intravenous Therapy Solutions Market Regional And Country Analysis

  • 7.1. Global Intravenous Therapy Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Intravenous Therapy Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intravenous Therapy Solutions Market

  • 8.1. Asia-Pacific Intravenous Therapy Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intravenous Therapy Solutions Market

  • 9.1. China Intravenous Therapy Solutions Market Overview
  • 9.2. China Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intravenous Therapy Solutions Market

  • 10.1. India Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intravenous Therapy Solutions Market

  • 11.1. Japan Intravenous Therapy Solutions Market Overview
  • 11.2. Japan Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intravenous Therapy Solutions Market

  • 12.1. Australia Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intravenous Therapy Solutions Market

  • 13.1. Indonesia Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intravenous Therapy Solutions Market

  • 14.1. South Korea Intravenous Therapy Solutions Market Overview
  • 14.2. South Korea Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intravenous Therapy Solutions Market

  • 15.1. Western Europe Intravenous Therapy Solutions Market Overview
  • 15.2. Western Europe Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intravenous Therapy Solutions Market

  • 16.1. UK Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intravenous Therapy Solutions Market

  • 17.1. Germany Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intravenous Therapy Solutions Market

  • 18.1. France Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intravenous Therapy Solutions Market

  • 19.1. Italy Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intravenous Therapy Solutions Market

  • 20.1. Spain Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intravenous Therapy Solutions Market

  • 21.1. Eastern Europe Intravenous Therapy Solutions Market Overview
  • 21.2. Eastern Europe Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intravenous Therapy Solutions Market

  • 22.1. Russia Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intravenous Therapy Solutions Market

  • 23.1. North America Intravenous Therapy Solutions Market Overview
  • 23.2. North America Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intravenous Therapy Solutions Market

  • 24.1. USA Intravenous Therapy Solutions Market Overview
  • 24.2. USA Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intravenous Therapy Solutions Market

  • 25.1. Canada Intravenous Therapy Solutions Market Overview
  • 25.2. Canada Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intravenous Therapy Solutions Market

  • 26.1. South America Intravenous Therapy Solutions Market Overview
  • 26.2. South America Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intravenous Therapy Solutions Market

  • 27.1. Brazil Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intravenous Therapy Solutions Market

  • 28.1. Middle East Intravenous Therapy Solutions Market Overview
  • 28.2. Middle East Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intravenous Therapy Solutions Market

  • 29.1. Africa Intravenous Therapy Solutions Market Overview
  • 29.2. Africa Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intravenous Therapy Solutions Market Competitive Landscape And Company Profiles

  • 30.1. Intravenous Therapy Solutions Market Competitive Landscape
  • 30.2. Intravenous Therapy Solutions Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

31. Intravenous Therapy Solutions Market Other Major And Innovative Companies

  • 31.1. Grifols S.A.
  • 31.2. Terumo Corporation
  • 31.3. Dr. Reddy's Laboratories Limited
  • 31.4. Sichuan Kelun Pharmaceutical Co. Ltd.
  • 31.5. Teleflex Incorporated
  • 31.6. Hikma Pharmaceuticals PLC
  • 31.7. ICU Medical Inc.
  • 31.8. Biocon Limited
  • 31.9. B. Braun Melsungen Aktiengesellschaft
  • 31.10. JW Life Science Corporation
  • 31.11. AdvaCare Pharma USA
  • 31.12. Soxa Formulations & Research Pvt. Ltd.
  • 31.13. Vifor Pharma Management Ltd.
  • 31.14. Aetos Pharma Private Limited
  • 31.15. LXIR Medilabs Private Limited

32. Global Intravenous Therapy Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intravenous Therapy Solutions Market

34. Recent Developments In The Intravenous Therapy Solutions Market

35. Intravenous Therapy Solutions Market High Potential Countries, Segments and Strategies

  • 35.1 Intravenous Therapy Solutions Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Intravenous Therapy Solutions Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Intravenous Therapy Solutions Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer